Web-Based Support Program for Caregivers of Lung Cancer Patients
(CONNECT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the Web-based Program treatment for caregivers of lung cancer patients?
Is the Web-Based Support Program for Caregivers of Lung Cancer Patients safe?
How is the Web-Based Support Program for Caregivers of Lung Cancer Patients different from other treatments?
This treatment is unique because it is a web-based program specifically designed to support caregivers of lung cancer patients, focusing on reducing their emotional and physical burden through information, communication, and coaching. Unlike traditional treatments that target the patient, this program addresses the needs of caregivers, helping them manage stress and improve their mood.2591011
What is the purpose of this trial?
Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.
Research Team
Kathryn Weaver, PhD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for adult caregivers providing unpaid care to someone with stage II-IV lung cancer. Caregivers must be able to use the internet and have a phone for navigation sessions. The patient must have started treatment with at least 9 weeks left, and both caregiver and patient need an ECOG status of 0-2.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete initial surveys to assess demographics, cancer symptoms, and caregiving experience
Intervention
Caregivers are randomized into one of three groups: CONNECT intervention, usual care, or generic resource list. CONNECT group receives personalized resources and navigator support
Follow-up
Participants complete follow-up surveys to assess retention, satisfaction, and resource utilization
Treatment Details
Interventions
- Web-based Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Cancer Institute (NCI)
Collaborator